NEW YORK (GenomeWeb News) - Pressure BioSciences has licensed rights to use technology developed by the Battelle Memorial Institute that PBI said can be used to improve systems for analyzing protein samples.
The technology, for which Battelle filed a patent this year, is related to a method and automated, in-line system using pressure and a pre-selected agent to obtain a digested sample faster than current methods while retaining the integrity of the sample throughout the preparatory process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.